OCTILIA INF COLL 1FL 10ML

OCTILIA ALLERGIA AND INFIAMMATION 3 MG/ML + 0.5 MG/ML COLLIRIO, SOLUTION

active ingredients

100 ml of solution contain: Active ingredients: Eccipient with known effect (10 ml bottle): benzalconio chloride For excipients v. 6.1

Excellent

Multi-dose bottle : Boric acid; Borace; Benzalconio Chloride; Water for injectable preparations. Single-dose container : Boric acid; Borace; Water for injectable preparations.

Therapeutic indications

In the allergic and inflammatory states of the conjunctiva accompanied by photophobia, tearing, feeling of foreign body, pain.

Contraindications

Hypersensitivity to the components of the product or other substances closely related to the chemical; in particular towards xilometazolina, oximetazolina, tetrizolina. Glaucoma at a narrow/closed angle or other severe eye diseases. Contraindicated in children under twelve years. Generally contraindicated during pregnancy and nursing (see par. 4.6). Contraindicated in the contemporary treatment with inhibiting drugs of monoaminoxydase (tranilcipromine, fenelzina, pargilina) (see par. 4.5).

Population

Instill in the affected eye 1-2 drops 2-3 times a day. Do not exceed the recommended doses. Strictly stick to the recommended doses. A higher dose of the product even if taken in a topical way and for a short period of time can give rise to serious systemic effects.

Conservation

Do not store above 25° C.

Warnings

The product, while presenting a very low systemic absorption, must be used with caution in subjects suffering from hypertension, hyperthyroidism, heart disorders, and hyperglycemia (diabetes). In case of persisting or aggravating symptoms after a short period of treatment invite the patient to consult the doctor. In any case, the product should not be used for more than 4 consecutive days, except for a different prescription, given the possibility that they may occur otherwise, side effects. The product, if accidentally ingested or used for long periods at excessive doses, can determine toxic phenomena. Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage, require medical intervention. Prolonged use of topical products can lead to awareness-raising. In this case it is necessary to stop treatment and establish suitable therapy. Important information about some excipients: This medicine contains 0.012 mg of benzalconio chloride for the recommended maximum daily dose of 6 drops (0.24 ml) equivalent to 0.05 mg/ml. The benzalconio chloride as preservative can be absorbed by soft contact lenses and can lead to change of their color, can give rise to awareness reactions and should not be applied while wearing contact lenses (in the case of contact lens wearers, wear the same only 15 minutes after the use of the product). Benzalconio chloride can also cause eye irritation especially if it has dry eye or cornea disorders (the most superficial transparent layer of the eye). In these cases you can use the monodose container that does not contain preservatives.

Interactions

OCTILIA ALLERGY AND INFIAMMATION should not be used in conjunction with the inhibition of monoaminoxydasis drugs, since this can determine the occurrence of severe hypertensive crises.

Effects

The use of the product can sometimes determine pupilal dilation, systemic effects from absorption (hypertension, heart disorders, hyperglycemia), increased blood pressure, nausea, headache. In children if accidentally ingested, the preparation can determine even deep sopore, and hypotonia. Rarely, phenomena of hypersensitivity can occur. In this case it is necessary to stop the treatment and establish suitable therapy. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk of the medicinal product. Healthcare professionals are required to report any adverse reaction suspected through the Italian Pharmaco Agency, Website: (https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse).

Overdosing

The product, if accidentally ingested or used for a long period at excessive doses, can determine toxic phenomena. Accidental ingestion of the drug, especially in children, can cause depression of the central nervous system: sedation marked (strong drowsiness), coma. If this happens, use gastric lavender and general support measures.

Data relating to the use of maleate phenyramine and tetrizoline hydrochloride in pregnant women do not exist or are in limited number. For precautionary purposes, it is preferable in pregnancy and during breastfeeding, use OCTILIA ALLERGY AND INFIAMMATION only in case of actual need, under the direct control of the doctor.

Source: Farmadati